2 EV Stocks That Are Too Cheap to Ignore Right Now

Rivian's R2 launch and cost efficiencies underpin expectations for a material recovery: production fell to 42,284 vehicles in 2025 but analysts forecast revenue to grow at a 45% CAGR from 2025–2028 and adjusted EBITDA to turn positive by 2028; Rivian trades with an enterprise value of $20.8B (~3x this year's sales) and aims to triple production by 2028 while launching the R3 in late 2026/early 2027. Nio delivered 326,028 vehicles in 2025 (from 20,565 in 2019) and historically grew revenue at a 40% CAGR; analysts expect 31% revenue CAGR from 2025–2027, adjusted EBITDA turning positive in 2026 and rising ~26% in 2027, with an EV of 115.8B yuan (~$16.9B) trading at under 1x sales. Both names are presented as high-growth but volatile opportunities amid supply-chain headwinds, intense competition, and macro/market risks.

Analysis

Rivian’s move to a simpler, lower-BOM architecture is a structural margin lever that will reallocate value along the supply chain: winners are large-structure casting and cell-format suppliers who can scale throughput, while harness, connector, and legacy ECU vendors face margin pressure. That shift also compresses variable assembly time and could materially shorten unit ramp cycles when plants hit steady state, making factory uptime and robotic integration the primary operational bottleneck rather than pure part supply.

For Nio, recurring-service models (battery-swap, subscriptions) create a higher-quality revenue mix that de-risks unit volatility; overseas expansion magnifies that benefit only if unit economics per market are preserved after localized capex and regulatory costs. Macroeconomic risk remains the dominant market swing factor — credit spreads, auto-loan availability, and subsidy cliffs will move volumes quickly, so earnings inflection points are as much macro-timed as product-timed.

Key tail risks are execution potholes: a single large casting supplier outage or an early R2 quality recall would compress free cash flow and force higher warranty provisioning over a multi-quarter window. Near-term catalysts to watch are first 3–6 month post-launch service rates (warranty incidence), Georgia plant commissioning milestones, and European swap-network utilization metrics for Nio; positive readings should re-rate multiple compression into multiple expansion within 12–24 months.

Key Decisions for Investors

• Long RIVN (size 1.5% NAV, horizon 12–36 months): buy equity and overlay 12-month puts (buy RIVN stock + buy 12m at-the-money puts) to cap downside to ~40% while allowing full upside if unit economics prove out; target 2.5x upside if margins move toward peers, stop-loss on put-exercise if warranty incidence > industry median over first 6 months.
• Long NIO / Short TSLA pair (net 1.0% NAV, horizon 12–24 months): 1% NAV long NIO funded by 0.5% NAV short TSLA to express faster growth per unit economics in China/Europe vs US luxury exposure; expect asymmetric payoff if Chinese premium demand normalizes — downside limited by stop when NIO EV/adj-EBITDA compression exceeds 25% vs cohort.
• Rivian calendar call spread (options, 0.5% NAV, horizon 9–18 months): buy longer-dated (18–24m) LEAP call and sell shorter-dated (6–9m) call to finance premium — objective is to capture re-rating at product-market fit while protecting against near-term volatility spikes; acceptable max loss = premium paid, target 3x intrinsic uplift if volume/margin cadence aligns.
• Risk hedge: buy NVDA or INTC small exposure (0.25% NAV) as convex insurance to an accelerated ADAS/software monetization scenario across OEMs — if incumbents push higher compute stacks, NVDA re-prices sharply; if not, keep allocation tactical and time-limited (6–12 months).